Vial, Liquid Spray, or Dissolving Strip: Research Peptide Formats Compared

Research-use-only context. This article summarizes published third-party scientific literature and laboratory practice. It is not medical advice, not a therapeutic or performance claim, and not a usage guide. US Prime Peptides products are supplied strictly for in vitro laboratory research and are not for human or veterinary use.

This article explains what a lyophilized vial, an aqueous liquid spray, and a dissolving strip each are as physical chemistry, how the label and certificate describe the content of each, and why their stability profiles differ. It is a formats reference for buyers who see one compound offered in several presentations and want to compare the paperwork.

Three formats, three physical states

A lyophilized vial holds the peptide as a dry solid, a liquid spray holds it dissolved in a preserved aqueous solution, and a dissolving strip holds it dispersed in a thin polymer film. Shelf life and the shape of the certificate both follow from those three states.

In the vial, freeze-drying removes the bulk water and leaves a porous cake in which the peptide, its counter-ion, and any bulking agent sit in a glassy or crystalline matrix with residual moisture usually in the low single-digit percent range. Wang's 2000 review in International Journal of Pharmaceutics describes why that matters: the reactions that degrade peptides in water, including hydrolysis, deamidation, and aggregation, need molecular mobility that a dry glass does not provide (what lyophilized means).

In the spray, the peptide is a solute. The bottle also contains a buffer that fixes pH, a tonicity agent such as sodium chloride or glycerol, a preservative because the container is opened more than once, and sometimes a chelator or a viscosity modifier. Wang's 1999 companion review covers the instability pathways that open up once water is present.

In the strip, a film former such as hypromellose, pullulan, or polyvinyl alcohol is cast with a plasticizer such as glycerol, and the peptide is distributed through the dried film. The European Medicines Agency's term for this technology is orodispersible film, abbreviated ODF, as Hoffmann, Breitenbach, and Breitkreutz explain in their 2011 review in Expert Opinion on Drug Delivery.

How the label states mass in each format

All three labels state a mass of peptide, but each states it against a different denominator: the vial reports mass per vial, the spray reports total mass per bottle together with the fill volume, and the strip reports mass per strip together with the number of strips in the pack.

For a vial such as Selank 10 mg, the label mass is the nominal peptide mass in the container. The certificate pairs it with HPLC purity, which describes the peptide fraction of the dissolved solid, and net peptide content, which accounts for counter-ions and water in the lyophilized mass (net peptide content versus purity).

For a spray such as Selank liquid spray 5 mg, the label mass is the total peptide dissolved in the bottle. Dividing by the fill volume gives the nominal concentration, and the certificate reports the measured concentration by assay in mg/mL, from which the total is back-calculated. Fill volume and deliverable volume differ because a pump retains a dead volume.

For a strip such as Selank / Semax dissolvable strips 1 mg + 1 mg per strip, 30 strips, the label mass is a per-unit claim repeated thirty times. That makes the certificate a statistical document: one assay is not enough, and the pack has to pass a content uniformity test across multiple units. USP <905> content uniformity is the usual reference method.

Stability: why the solid outlasts the solution

A lyophilized solid is the most stable of the three formats because the chemistry that degrades a peptide largely requires water as a reactant or as a medium for molecular motion. Manning and colleagues' 2010 update in Pharmaceutical Research catalogs those pathways: deamidation of asparagine and glutamine, hydrolysis of acid-labile bonds, oxidation of methionine, cysteine, and tryptophan, racemization, and physical aggregation.

In solution, every one of those reactions has a measurable rate at refrigerator temperature, and the rate depends on pH, buffer species, ionic strength, and headspace oxygen. The preservative adds a further variable. Thirumangalathu and colleagues reported in a 2006 Journal of Pharmaceutical Sciences paper that benzyl alcohol promoted aggregation of a recombinant protein in a way that depended on pH, temperature, and sucrose content, and Stroppel and colleagues' 2023 overview in Pharmaceutics summarizes similar preservative-protein interactions across many formulations.

A film sits between the two: water is present but mostly bound in the polymer, so solution-phase chemistry is slowed rather than stopped. Casting and drying, however, heat the peptide while it is still in a wet matrix. Gil and colleagues reported in a 2023 International Journal of Pharmaceutics study that the nonapeptide desmopressin acetate degraded under the heat of film manufacture, and that xanthan gum in the film reduced total impurities over six months of accelerated storage.

Stability programs for all three formats follow ICH Q1A(R2): long-term storage at the labeled condition, an accelerated condition at elevated temperature and humidity, and pull points at which assay, related substances, and physical attributes are re-measured.

What a certificate looks like for each format

A vial certificate is a raw-material document, while spray and strip certificates are finished-product documents, so they answer different questions and should not be read against the same checklist. The vial certificate describes a peptide; the other two describe a formulation in which the peptide is a minor component by mass.

A lot-matched vial certificate from an independent US laboratory typically lists identity by mass spectrometry, purity by HPLC, net peptide content, endotoxin by LAL, sterility, and heavy metals by ICP-MS. Its impurities are peptide-related: deletion sequences, oxidized variants, residual trifluoroacetate.

A spray certificate adds pH, osmolality by USP <785>, preservative identity and content, and either a USP <51> antimicrobial effectiveness result or a reference to the preservative system's qualification. Its HPLC method has to separate the peptide from the preservative peak, and its assay is expressed as a concentration.

A strip certificate adds average film mass, mass per strip for each active, a content uniformity acceptance value, residual moisture or loss on drying, and an in vitro disintegration time. Preis and colleagues noted in a 2013 review in Expert Opinion on Drug Delivery that film-specific characterization methods were not yet harmonized across pharmacopoeias, so the method used should be stated on the certificate rather than assumed.

What each format presents to the analyst

Analytically, the vial offers the most control, the spray a fixed preserved matrix, and the strip a solid-state polymer system; the right choice depends on which of those a laboratory wants to study or avoid. This concerns only what arrives on the bench and what the method must account for.

With a vial, the laboratory chooses the solvent, the concentration, the buffer, and the container, and it can run the peptide on HPLC with no excipient background. That makes it the natural format for identity and purity work, and for any study where the peptide must be the only variable.

With a spray, the formulation is fixed. Preservative, buffer, and tonicity agent all appear in the chromatogram and in any cell-based assay, so the method must be shown to be specific for the peptide in that matrix. The spray is the right object of study when the question is preserved-solution stability, pump performance, or excipient compatibility.

With a strip, the questions are solid-state: polymer dissolution, water uptake, content uniformity across a sheet, and how a peptide survives casting. Extracting a small mass of peptide from a polymer film is itself a method-development task; Hoffmann and colleagues' 2011 review lists the characterization methods film laboratories use.

Reading one compound across formats: the Selank example

Selank in a 10 mg vial, Selank in a 5 mg spray, and Selank paired with Semax at 1 mg + 1 mg per strip are three products with three certificates, even though the heptapeptide is the same molecule in each. On paper the comparison is a mass comparison with different denominators.

The vial's 10 mg is a dry mass with purity and net content attached. The spray's 5 mg is dissolved in a stated fill volume with a measured concentration attached. The strip's 1 mg is one of thirty units, so the pack contains a nominal 30 mg of Selank and 30 mg of Semax, and the certificate must report both peptides separately with their own identity, assay, and uniformity results (reading a blend certificate).

Two further lines matter. The related-substances line: methionine-containing Semax can show an oxidized variant that grows faster in solution than in a dry solid, so the same impurity reads differently by format and lot age. And the storage history, which no certificate captures and which the receiving laboratory should log itself (peptide storage and stability).

Frequently Asked Questions

Is a peptide liquid spray the same compound as the lyophilized vial?

The peptide sequence is the same, but the product is not. A spray is a formulation that also contains buffer, tonicity agent, and preservative in water, and its certificate reports a concentration and total mass rather than the purity and net content reported for a dry vial. Confirm the molecule on the mass spectrometry identity line, then read each certificate on its own terms.

Why does a lyophilized vial have a longer shelf life than a liquid spray?

Because the reactions that degrade peptides, including deamidation, hydrolysis, and oxidation, need water as a reactant or as a medium for molecular motion. A freeze-dried cake with a few percent residual moisture slows those reactions dramatically, while a solution lets them proceed at a pH- and temperature-dependent rate from the day it is filled.

What does "per strip" mean on a dissolving strip label?

It is the nominal mass of each active in one film unit, and the pack contains a stated number of those units. Because the claim is repeated across every strip, the certificate should include a content uniformity result such as a USP <905> acceptance value, not just a single assay, to show that individual strips do not scatter widely around the label mass.

Which tests should a spray or strip certificate include that a vial certificate does not?

A spray certificate should add pH, osmolality, preservative content, and antimicrobial effectiveness or microbial limits. A strip certificate should add average film mass, mass per strip for each active, content uniformity, residual moisture, and an in vitro disintegration time, with the method named.

Citations

1. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. PMID 10967427
2. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. PMID 10460913
3. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. PMID 20143256
4. Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Expert Opin Drug Deliv. 2011;8(3):299-316. PMID 21284577
5. Preis M, Woertz C, Kleinebudde P, Breitkreutz J. Oromucosal film preparations: classification and characterization methods. Expert Opin Drug Deliv. 2013;10(9):1303-1317. PMID 23768198
6. Stroppel L, Schultz-Fademrecht T, Cebulla M, Blech M, Marhöfer RJ, Selzer PM, Garidel P. Antimicrobial Preservatives for Protein and Peptide Formulations: An Overview. Pharmaceutics. 2023;15(2):563. PMID 36839885
7. Thirumangalathu R, Krishnan S, Brems DN, Randolph TW, Carpenter JF. Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor. J Pharm Sci. 2006;95(7):1480-1497. PMID 16729274
8. Gil MC, Park SJ, Lee BS, Park C, Lee BJ. Dual thermal stabilizing effects of xanthan gums via glycosylation and hydrogen bonding and in vivo human bioavailability of desmopressin in orodispersible film. Int J Pharm. 2023;637:122879. PMID 36958609
9. United States Pharmacopeia. USP <905> content uniformity; USP <51> antimicrobial effectiveness testing; USP <785> osmolality and osmolarity. USP-NF. current edition. USP-NF
10. International Council for Harmonisation. ICH Q1A(R2): Stability Testing of New Drug Substances and Products. ICH Harmonised Guideline. 2003. ICH Q1A(R2)

This article is for laboratory research reference only. US Prime Peptides products are supplied strictly for in vitro research. Not for human consumption.

Compliance Notice: US Prime Peptides products are supplied strictly for laboratory and academic research purposes only. They are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. All content on this page is educational in nature and does not constitute medical advice or product claims. Researchers are responsible for handling these compounds in accordance with their institution’s safety protocols and applicable laws.